BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30962288)

  • 21. Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells.
    Farhan F; Trivedi M; Di Wu P; Cui W
    Stem Cell Res Ther; 2023 Nov; 14(1):314. PubMed ID: 37907977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research.
    Takayama K; Hagihara Y; Toba Y; Sekiguchi K; Sakurai F; Mizuguchi H
    Biomaterials; 2018 Apr; 161():24-32. PubMed ID: 29421559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity.
    Kondo Y; Iwao T; Nakamura K; Sasaki T; Takahashi S; Kamada N; Matsubara T; Gonzalez FJ; Akutsu H; Miyagawa Y; Okita H; Kiyokawa N; Toyoda M; Umezawa A; Nagata K; Matsunaga T; Ohmori S
    Drug Metab Pharmacokinet; 2014; 29(3):237-43. PubMed ID: 24334537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
    Nagamoto Y; Takayama K; Tashiro K; Tateno C; Sakurai F; Tachibana M; Kawabata K; Ikeda K; Tanaka Y; Mizuguchi H
    Cell Transplant; 2015; 24(6):1127-38. PubMed ID: 24806294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
    Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
    Sci Rep; 2017 Jan; 7():41238. PubMed ID: 28120901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically based pharmacokinetic modeling for sequential metabolism: effect of CYP2C19 genetic polymorphism on clopidogrel and clopidogrel active metabolite pharmacokinetics.
    Djebli N; Fabre D; Boulenc X; Fabre G; Sultan E; Hurbin F
    Drug Metab Dispos; 2015 Apr; 43(4):510-22. PubMed ID: 25609219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.
    Kia R; Kelly L; Sison-Young RL; Zhang F; Pridgeon CS; Heslop JA; Metcalfe P; Kitteringham NR; Baxter M; Harrison S; Hanley NA; Burke ZD; Storm MP; Welham MJ; Tosh D; Küppers-Munther B; Edsbagge J; Starkey Lewis PJ; Bonner F; Harpur E; Sidaway J; Bowes J; Fenwick SW; Malik H; Goldring CE; Park BK
    Toxicol Sci; 2015 Mar; 144(1):173-85. PubMed ID: 25527335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
    Yu Y; Liu H; Ikeda Y; Amiot BP; Rinaldo P; Duncan SA; Nyberg SL
    Stem Cell Res; 2012 Nov; 9(3):196-207. PubMed ID: 22885101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies.
    Yamashita T; Takayama K; Hori M; Harada-Shiba M; Mizuguchi H
    Biol Pharm Bull; 2019; 42(3):312-318. PubMed ID: 30828061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human iPS Cell-based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B.
    Okamoto R; Takayama K; Akita N; Nagamoto Y; Hosokawa D; Iizuka S; Sakurai F; Suemizu H; Ohashi K; Mizuguchi H
    Cell Transplant; 2018 Feb; 27(2):299-309. PubMed ID: 29637813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds.
    Vanmarcke G; Sai-Hong Chui J; Cooreman A; De Vos K; Cleuren L; Van Rossom R; García-Llorens G; Izuel Idoype T; Boon R; Kumar Gautam M; Castell JV; Annaert P; Lluis F; Verfaillie CM
    Stem Cells; 2023 Nov; 41(11):1076-1088. PubMed ID: 37616601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting.
    González A; Moniche F; Cayuela A; García-Lozano JR; Torrecillas F; Escudero-Martínez I; Gonzalez-Marcos JR; Mayol A; Montaner J
    Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):175-86. PubMed ID: 26526111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanaomycin A Treatment Promotes Hepatoblast Differentiation from Human iPS Cells.
    Nakamae S; Toba Y; Takayama K; Sakurai F; Mizuguchi H
    Stem Cells Dev; 2018 Mar; 27(6):405-414. PubMed ID: 29378471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.
    Song Z; Cai J; Liu Y; Zhao D; Yong J; Duo S; Song X; Guo Y; Zhao Y; Qin H; Yin X; Wu C; Che J; Lu S; Ding M; Deng H
    Cell Res; 2009 Nov; 19(11):1233-42. PubMed ID: 19736565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes.
    Zabulica M; Srinivasan RC; Vosough M; Hammarstedt C; Wu T; Gramignoli R; Ellis E; Kannisto K; Collin de l'Hortet A; Takeishi K; Soto-Gutierrez A; Strom SC
    Stem Cells Dev; 2019 Jul; 28(14):907-919. PubMed ID: 31122128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models.
    Toivonen S; Malinen MM; Küblbeck J; Petsalo A; Urtti A; Honkakoski P; Otonkoski T
    Tissue Eng Part A; 2016 Jul; 22(13-14):971-84. PubMed ID: 27329070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.